Recent Updates
Recently added Catalysts
IDYA

IDEAYA Biosciences Reports IDE397 Interim Phase 1 Clinical Data

Tuesday, March 15, 2022 1 min read
Key Takeaway: IDEAYA Biosciences Reports IDE397 Interim Phase 1 Clinical Data

Full Press Release Details

IDEAYA Biosciences Reports IDE397 Interim Phase 1 Clinical Data.
Tags: IDYA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Mar 15, 2022